One Step at a Time: <i>CYP2D6</i> Guided Tamoxifen Treatment Awaits Convincing Evidence of Clinical Validity

Name: Work Video:
Duration: 3 min 30 s
Description: Without convincing evidence of clinical validity of this association there is no rational basis for CYP2D6 guided tamoxifen treatment.Recent studies confirm the feasibility and safety of genotype guided treatment, but the efficacy of this approach has not been assessed.
Daniel L. Hertz; James M. Rae
{'id': 'https://openalex.org/W2417084101', 'doi': 'https://doi.org/10.2217/pgs-2016-0059', 'title': 'One Step at a Time: <i>CYP2D6</i> Guided Tamoxifen Treatment Awaits Convincing Evidence of Clinical Validity', 'display_name': 'One Step at a Time: <i>CYP2D6</i> Guided Tamoxifen Treatment Awaits Convincing Evidence of Clinical Validity', 'publication_year': 2016, 'publication_date': '2016-06-01', 'ids': {'openalex': 'https://openalex.org/W2417084101', 'doi': 'https://doi.org/10.2217/pgs-2016-0059', 'mag': '2417084101', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/27249031'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.2217/pgs-2016-0059', 'pdf_url': 'https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2016-0059', 'source': {'id': 'https://openalex.org/S190377370', 'display_name': 'Pharmacogenomics', 'issn_l': '1462-2416', 'issn': ['1462-2416', '1744-8042'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310321119', 'host_organization_name': 'Future Medicine', 'host_organization_lineage': ['https://openalex.org/P4310321119'], 'host_organization_lineage_names': ['Future Medicine'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2016-0059', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5075359631', 'display_name': 'Daniel L. Hertz', 'orcid': 'https://orcid.org/0000-0003-0501-1035'}, 'institutions': [{'id': 'https://openalex.org/I27837315', 'display_name': 'University of Michigan–Ann Arbor', 'ror': 'https://ror.org/00jmfr291', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I27837315']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Daniel L Hertz', 'raw_affiliation_strings': ['Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI, USA', 'institution_ids': ['https://openalex.org/I27837315']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5052071953', 'display_name': 'James M. Rae', 'orcid': 'https://orcid.org/0000-0002-3412-8219'}, 'institutions': [{'id': 'https://openalex.org/I27837315', 'display_name': 'University of Michigan–Ann Arbor', 'ror': 'https://ror.org/00jmfr291', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I27837315']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'James M Rae', 'raw_affiliation_strings': ['Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA'], 'affiliations': [{'raw_affiliation_string': 'Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA', 'institution_ids': ['https://openalex.org/I27837315']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5075359631'], 'corresponding_institution_ids': ['https://openalex.org/I27837315'], 'apc_list': None, 'apc_paid': None, 'fwci': 2.066, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 16, 'citation_normalized_percentile': {'value': 0.835268, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 89, 'max': 90}, 'biblio': {'volume': '17', 'issue': '8', 'first_page': '823', 'last_page': '826'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10756', 'display_name': 'Estrogen and related hormone effects', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/1311', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10756', 'display_name': 'Estrogen and related hormone effects', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/1311', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10375', 'display_name': 'Pharmacogenetics and Drug Metabolism', 'score': 0.9993, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10678', 'display_name': 'Inflammatory mediators and NSAID effects', 'score': 0.9954, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C2777176818', 'wikidata': 'https://www.wikidata.org/wiki/Q412178', 'display_name': 'Tamoxifen', 'level': 4, 'score': 0.81882465}, {'id': 'https://openalex.org/C33664856', 'wikidata': 'https://www.wikidata.org/wiki/Q3271142', 'display_name': 'CYP2D6', 'level': 4, 'score': 0.62641096}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.42840296}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.39506993}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.31861436}, {'id': 'https://openalex.org/C530470458', 'wikidata': 'https://www.wikidata.org/wiki/Q128581', 'display_name': 'Breast cancer', 'level': 3, 'score': 0.20811307}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.14126164}, {'id': 'https://openalex.org/C526171541', 'wikidata': 'https://www.wikidata.org/wiki/Q407693', 'display_name': 'Cytochrome P450', 'level': 3, 'score': 0.0}, {'id': 'https://openalex.org/C62231903', 'wikidata': 'https://www.wikidata.org/wiki/Q1057', 'display_name': 'Metabolism', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D001943', 'descriptor_name': 'Breast Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D019389', 'descriptor_name': 'Cytochrome P-450 CYP2D6', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': True}, {'descriptor_ui': 'D013629', 'descriptor_name': 'Tamoxifen', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D001943', 'descriptor_name': 'Breast Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001943', 'descriptor_name': 'Breast Neoplasms', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D019389', 'descriptor_name': 'Cytochrome P-450 CYP2D6', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005838', 'descriptor_name': 'Genotype', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013629', 'descriptor_name': 'Tamoxifen', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013629', 'descriptor_name': 'Tamoxifen', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D013629', 'descriptor_name': 'Tamoxifen', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.2217/pgs-2016-0059', 'pdf_url': 'https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2016-0059', 'source': {'id': 'https://openalex.org/S190377370', 'display_name': 'Pharmacogenomics', 'issn_l': '1462-2416', 'issn': ['1462-2416', '1744-8042'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310321119', 'host_organization_name': 'Future Medicine', 'host_organization_lineage': ['https://openalex.org/P4310321119'], 'host_organization_lineage_names': ['Future Medicine'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/27249031', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.2217/pgs-2016-0059', 'pdf_url': 'https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2016-0059', 'source': {'id': 'https://openalex.org/S190377370', 'display_name': 'Pharmacogenomics', 'issn_l': '1462-2416', 'issn': ['1462-2416', '1744-8042'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310321119', 'host_organization_name': 'Future Medicine', 'host_organization_lineage': ['https://openalex.org/P4310321119'], 'host_organization_lineage_names': ['Future Medicine'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.59}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 23, 'referenced_works': ['https://openalex.org/W1836143067', 'https://openalex.org/W1978470279', 'https://openalex.org/W1985458022', 'https://openalex.org/W2034897616', 'https://openalex.org/W2069469265', 'https://openalex.org/W2073367400', 'https://openalex.org/W2082048952', 'https://openalex.org/W2082160386', 'https://openalex.org/W2104019649', 'https://openalex.org/W2104058573', 'https://openalex.org/W2118728607', 'https://openalex.org/W2120384798', 'https://openalex.org/W2122090386', 'https://openalex.org/W2131043327', 'https://openalex.org/W2135502243', 'https://openalex.org/W2147225212', 'https://openalex.org/W2154067964', 'https://openalex.org/W2158635723', 'https://openalex.org/W2159226865', 'https://openalex.org/W2161109798', 'https://openalex.org/W2193372584', 'https://openalex.org/W2407393655', 'https://openalex.org/W2936189318'], 'related_works': ['https://openalex.org/W4361808793', 'https://openalex.org/W3116590137', 'https://openalex.org/W3088326324', 'https://openalex.org/W2901578746', 'https://openalex.org/W2769256842', 'https://openalex.org/W2325525898', 'https://openalex.org/W2314827670', 'https://openalex.org/W2158973032', 'https://openalex.org/W2132843748', 'https://openalex.org/W2113911245'], 'abstract_inverted_index': {'Without': [0], 'convincing': [1], 'evidence': [2], 'of': [3, 6, 25, 32], 'clinical': [4], 'validity': [5], 'this': [7, 33], 'association': [8], 'there': [9], 'is': [10], 'no': [11], 'rational': [12], 'basis': [13], 'for': [14], 'CYP2D6': [15], 'guided': [16, 27], 'tamoxifen': [17], 'treatment.Recent': [18], 'studies': [19], 'confirm': [20], 'the': [21, 30], 'feasibility': [22], 'and': [23], 'safety': [24], 'genotype': [26], 'treatment,': [28], 'but': [29], 'efficacy': [31], 'approach': [34], 'has': [35], 'not': [36], 'been': [37], 'assessed.': [38]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2417084101', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 4}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 6}], 'updated_date': '2025-01-06T05:28:36.682941', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
